Refine
Year of publication
Document Type
- Preprint (669)
- Article (439)
- Conference Proceeding (5)
- Doctoral Thesis (1)
- Part of Periodical (1)
- Working Paper (1)
Has Fulltext
- yes (1116)
Is part of the Bibliography
- no (1116)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- Heavy-ion collision (6)
- ALICE experiment (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- ALICE (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- pp collisions (3)
- Beauty production (2)
- Charm physics (2)
- Diagnostik (2)
- Energiebereitstellung (2)
- Entzündung (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Früherkennung (2)
- Gewebedurchblutung (2)
- Gewebetemperatur (2)
- HOD (2)
- Heavy Quark Production (2)
- Human behaviour (2)
- Infektionsabwehr (2)
- Lebensqualität (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Mammakarzinom (2)
- Nachsorge (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Problemwunden (2)
- Psychiatric disorders (2)
- QCD (2)
- Richtlinie (2)
- Sauerstoffpartialdruck im Gewebe (2)
- Sauerstoffversorgung (2)
- Schmerzminderung (2)
- Single electrons (2)
- Wundheilung (2)
- Wundinfektionen (2)
- Wundsekretion (2)
- acute wounds (2)
- akute Wunden (2)
- breast cancer (2)
- diagnosis (2)
- energy supply (2)
- follow‑up (2)
- guideline (2)
- infection defense (2)
- inflammation (2)
- oxygen supply (2)
- problem wounds (2)
- prospective, randomized, controlled, double-blind studies (2)
- reduction of pain (2)
- screening (2)
- temperaturabhängige und temperaturunabhängige Effekte (2)
- thermal and non-thermal effects (2)
- thermic and non-thermic effects (2)
- thermische und nicht-thermische Effekte (2)
- tissue blood flow (2)
- tissue oxygen partial pressure (2)
- tissue temperature (2)
- visual analog scales (VAS) (2)
- visuelle Analogskalen (VAS) (2)
- wassergefiltertes Infrarot A (wIRA) (2)
- water-filtered infrared-A (wIRA) (2)
- wound exudation (2)
- wound healing (2)
- wound infections (2)
- 900 GeV (1)
- ALICE detector (1)
- Acuris (1)
- Acute myeloid leukemia (1)
- Adhesion (1)
- All-trans retinoic acid (1)
- Anti-nuclei (1)
- Antirheumatic agents (1)
- Anxiety (1)
- Anxiety disorders (1)
- Ataxia-telangiectasia (1)
- Automobile Exhaust (1)
- Baryonic resonances (1)
- Bibliographie (1)
- Bidirectional genes (1)
- Boosted Jets (1)
- CAD/ CAM crown (1)
- CMS (1)
- CVID (1)
- Cardiomyocyte signaling pathways (1)
- Cardioprotection (1)
- Cardiovascular disease (1)
- Carotenoids (1)
- Cellulase (1)
- Cellulases (1)
- Centrality Class (1)
- Centrality Selection (1)
- Child (1)
- Chlorophyll Formation (1)
- Clinical trial (1)
- Collective Flow, (1)
- Colorectal cancer (1)
- Comorbidities (1)
- Comparative effectiveness research (1)
- Comparison with QCD (1)
- Consensus (1)
- Cucumis sativus (Cucumber) (1)
- CyberKnife (1)
- Dermatomyositis (1)
- Deutschland (1)
- Devic disease (1)
- Devic syndrome (1)
- Diagnosis (1)
- Drug targeting (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Endothelial permeability (1)
- Energieumsatz <Medizin> (1)
- Epigenetics (1)
- Ethiopia (1)
- European Society for Immunodeficiencies (ESID) (1)
- Extended donor criteria (1)
- Extracellular RNA (eRNA) (1)
- Extreme hypo-fractionation (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Film (1)
- Flagellaten (1)
- Flagellates (1)
- Freezeout (1)
- Galleria mellonella (1)
- German PID-NET registry (1)
- Geschichte 1933-1945 (1)
- HBT (1)
- HUVEC (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hard Scattering (1)
- Heart regeneration (1)
- Heat-Bleaching (of Plastids) (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Heavy-ion reactions (1)
- Historikerstreit <1986-1989> (1)
- Holmes tremor (1)
- Hyperons (1)
- IgA deficiency (1)
- IgG substitution therapy (1)
- Immunodeficiency (1)
- Immunoglobulins (1)
- Inclusive spectra (1)
- Induced pluripotent stem cells (1)
- Infrarot (1)
- Intensity interferometry (1)
- Interpersonal relationships (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Ischemia–reperfusion injury (1)
- Isoprenoids (1)
- JAWSTAT pathway (1)
- Jet Physics (1)
- Jet Substructure (1)
- Kontroverse (1)
- Latent Injury (1)
- Lipid metabolism (1)
- Localized prostate cancer (1)
- Lymphopenia Mortality (1)
- Mastotermes (1)
- Material budget (1)
- Menschenversuch (1)
- Mental health therapies (1)
- Mevalonic Acid (1)
- MicroRNAs (miRNAs) (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Mitochondria (1)
- Molecular neuroscience (1)
- Monte Carlo (1)
- Mortality (1)
- Multi-Parton Interactions (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- N immission (1)
- NMO-IgG (1)
- Neural network (1)
- Neuromyelitis optica (1)
- Nuclear modification factor (1)
- Nucleophosmin-1 (1)
- Nucleus (1)
- Organ allocation (1)
- Oxidative Stress (1)
- Ozone (1)
- PID prevalence (1)
- PPARγ (1)
- PYTHIA (1)
- Pancreas transplantation (1)
- Particle and Resonance Production (1)
- Patients (1)
- Pb–Pb (1)
- Personalized medicine (1)
- Predictive markers (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Proton (1)
- Proton–proton (1)
- Psychometrics (1)
- Psychotherapy (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- Questionnaires (1)
- Rapidity Range (1)
- Rejection (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Remote ischemic conditioning (1)
- Resolution Parameter (1)
- Robotic Radiosurgery (1)
- SO2 reduction (1)
- STAT3 (1)
- Schmerz (1)
- Sekretion (1)
- Single muons (1)
- Single-cell RNA-seq (1)
- Spirocheten (1)
- Spirochetes (1)
- Stereotactic body radiation therapy (1)
- Strangeness (1)
- Systematic Uncertainty (1)
- TR (1)
- Termiten (1)
- Termites (1)
- Tigray (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Vector Boson Production (1)
- Vergangenheitsbewältigung (1)
- Viktor von ; Ärzteprozess ; Kontroverse (1)
- Weizsäcker (1)
- Weizsäcker, Viktor von (1)
- Wunde (1)
- Wundinfektion (1)
- Xenon-based gas mixture (1)
- antiviral therapy (1)
- aquaporin-4 (AQP4) antibody (1)
- axions (1)
- bacterial leakage (1)
- biogeographic legaciese (1)
- biomarker (1)
- cell proliferation (1)
- cerebellar mutism (1)
- cerebellum (1)
- cerebrospinal fluid (1)
- chronic viral hepatitis (1)
- cirrhosis (1)
- climatic change (1)
- clinical features (1)
- clinically important restrictions and symptoms (1)
- conical coupling (1)
- conometric connection (1)
- dE/dx (1)
- dark matter experiments (1)
- detector (1)
- doppeltblinde Studien (1)
- endothelial cells (1)
- epidemiology (1)
- everolimus (1)
- experimental results (1)
- forest classification (1)
- forest functional similarity (1)
- glioblastoma survival (1)
- health-related quality of life (1)
- heavy ion experiments (1)
- hepatitis c (1)
- honey bee classification (1)
- host cell response (1)
- kontrollierte Studien (1)
- longitudinally extensive transverse myelitis (1)
- magnetic resonance imaging (1)
- marginal fit (1)
- medulloblastoma (1)
- medulloblastoma resection (1)
- metabolic syndrome (1)
- metastatic renal cell carcinoma (1)
- montelukast (1)
- mtDNA haplotypes (1)
- neurosurgery (1)
- observational study (1)
- palatal tremor (1)
- phase IV (1)
- phylogenetic community distance (1)
- polypharmacology (1)
- posterior fossa masses (1)
- pranlukast (1)
- primary immunodeficiency (PID) (1)
- prospektive Studien (1)
- prospektive, randomisierte, kontrollierte, doppeltblinde Studien (1)
- pulmonary embolism (1)
- quality of lif (1)
- quality of life (1)
- quark gluon plasma (1)
- randomisierte Studien (1)
- range expansion (1)
- rare disease (1)
- recurrence pattern (1)
- recurrent optic neuritis (1)
- registry for primary immunodeficiency (1)
- sarcoma (1)
- second-line (1)
- solar physics (1)
- soluble epoxide hydrolase (1)
- spectra (1)
- therapeutic anticoagulation (1)
- tropical forests (1)
- white and brown dwarfs (1)
- wing geometric morphometrics (1)
- xenograft (1)
- zafirlukast (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1052)
- Frankfurt Institute for Advanced Studies (FIAS) (954)
- Informatik (920)
- Medizin (40)
- Biowissenschaften (8)
- Geowissenschaften (4)
- Informatik und Mathematik (3)
- Biochemie und Chemie (2)
- Biodiversität und Klima Forschungszentrum (BiK-F) (2)
- Gesellschaftswissenschaften (2)
We present the measured correlation functions for pi+ pi-, pi- pi- and pi+ pi+ pairs in central S+Ag collisions at 200 GeV per nucleon. The Gamov function, which has been traditionally used to correct the correlation functions of charged pions for the Coulomb interaction, is found to be inconsistent with all measured correlation functions. Certain problems which have been dominating the systematic uncertainty of the correlation analysis are related to this inconsistency. It is demonstrated that a new Coulomb correction method, based exclusively on the measured correlation function for pi+ pi- pairs, may solve the problem.
The NA35 experiment has collected a high statistics set of momentum analyzed negative hadrons near and forward of midrapidity for central collisions of 200A GeV/c 32S+S, Cu, Ag, and Au. Using momentum space correlations to study the size of the source of particle production, the transverse source radii are found to decrease by ~40% at midrapidity and ~20% at forward rapidity while the longitudinal radius RL is found to decrease by ~50% as pT increases over the interval 50<pT<600 MeV/c. Calculations using a microscopic phase space approach (relativistic quantum molecular dynamics) reproduce the observed trends of the data. PACS: 25.75.+r
Ziele: Das Ziel dieser offiziellen Leitlinie, die von der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG) und der Deutschen Krebsgesellschaft (DKG) publiziert und koordiniert wurde, ist es, die Früherkennung, Diagnostik, Therapie und Nachsorge des Mammakarzinoms zu optimieren.
Methoden: Der Aktualisierungsprozess der S3-Leitlinie aus 2012 basierte zum einen auf der Adaptation identifizierter Quellleitlinien und zum anderen auf Evidenzübersichten, die nach Entwicklung von PICO-(Patients/Interventions/Control/Outcome-)Fragen, systematischer Recherche in Literaturdatenbanken sowie Selektion und Bewertung der gefundenen Literatur angefertigt wurden. In den interdisziplinären Arbeitsgruppen wurden auf dieser Grundlage Vorschläge für Empfehlungen und Statements erarbeitet, die im Rahmen von strukturierten Konsensusverfahren modifiziert und graduiert wurden.
Empfehlungen: Der Teil 1 dieser Kurzversion der Leitlinie zeigt Empfehlungen zur Früherkennung, Diagnostik und Nachsorge des Mammakarzinoms: Der Stellenwert des Mammografie-Screenings wird in der aktualisierten Leitlinienversion bestätigt und bildet damit die Grundlage der Früherkennung. Neben den konventionellen Methoden der Karzinomdiagnostik wird die Computertomografie (CT) zum Staging bei höherem Rückfallrisiko empfohlen. Die Nachsorgekonzepte beinhalten Untersuchungsintervalle für die körperliche Untersuchung, Ultraschall und Mammografie, während weiterführende Gerätediagnostik und Tumormarkerbestimmungen bei der metastasierten Erkrankung Anwendung finden.
Purpose: The aim of this official guideline coordinated and published by the German Society for Gynecology and Obstetrics (DGGG) and the German Cancer Society (DKG) was to optimize the screening, diagnosis, therapy and follow-up care of breast cancer.
Methods: The process of updating the S3 guideline dating from 2012 was based on the adaptation of identified source guidelines which were combined with reviews of evidence compiled using PICO (Patients/Interventions/Control/Outcome) questions and the results of a systematic search of literature databases and the selection and evaluation of the identified literature. The interdisciplinary working groups took the identified materials as their starting point to develop recommendations and statements which were modified and graded in a structured consensus procedure.
Recommendations: Part 1 of this short version of the guideline presents recommendations for the screening, diagnosis and follow-up care of breast cancer. The importance of mammography for screening is confirmed in this updated version of the guideline and forms the basis for all screening. In addition to the conventional methods used to diagnose breast cancer, computed tomography (CT) is recommended for staging in women with a higher risk of recurrence. The follow-up concept includes suggested intervals between physical, ultrasound and mammography examinations, additional high-tech diagnostic procedures, and the determination of tumor markers for the evaluation of metastatic disease.
Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs.
Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel.
Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1–25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0–88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE- syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%—subcutaneous; 29%—intravenous; 1%—unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy.
Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment.
The transverse momentum and rapidity distributions of negative hadrons and participant protons have been measured for central 32S+ 32S collisions at plab=200 GeV/c per nucleon. The proton mean rapidity shift < Delta y>~1.6 and mean transverse momentum <pT>~0.6 GeV/c are much higher than in pp or peripheral AA collisions and indicate an increase in the nuclear stopping power. All pT spectra exhibit similar source temperatures. Including previous results for K0s Lambda , and Lambda -bar, we account for all important contributions to particle production.
The first measurement of ϕ-meson production in p-Pb collisions at a nucleon-nucleon centre-of-mass energy sNN−−−√ = 5.02 TeV has been performed with the ALICE apparatus at the LHC. The ϕ-mesons have been identified in the dimuon decay channel in the transverse momentum (pT) range 1<pT<7 GeV/c, both in the p-going (2.03<y<3.53) and the Pb-going (−4.46<y<−2.96) directions, where y stands for the rapidity in the nucleon-nucleon centre-of-mass. Differential cross sections as a function of transverse momentum and rapidity are presented. The forward-backward asymmetry for ϕ-meson production is measured for 2.96<|y|<3.53, resulting in a factor ∼0.5 with no significant pT dependence within the uncertainties. The pT dependence of the ϕ nuclear modification factor RpPb exhibits an enhancement up to a factor 1.6 at pT = 3-4 GeV/c in the Pb-going direction. The pT dependence of the ϕ-meson cross section in pp collisions at s√ = 2.76 TeV, which is used to determine a reference for the p-Pb results, is also presented here for 1<pT<5 GeV/c and 2.5<y<4.
We report on results obtained with the Event Shape Engineering technique applied to Pb-Pb collisions at sNN−−−√=2.76 TeV. By selecting events in the same centrality interval, but with very different average flow, different initial state conditions can be studied. We find the effect of the event-shape selection on the elliptic flow coefficient v2 to be almost independent of transverse momentum pT, as expected if this effect is due to fluctuations in the initial geometry of the system. Charged hadron, pion, kaon, and proton transverse momentum distributions are found to be harder in events with higher-than-average elliptic flow, indicating an interplay between radial and elliptic flow.
Transverse momentum (pT) spectra of pions, kaons, and protons up to pT=20 GeV/c have been measured in Pb-Pb collisions at sNN−−−√=2.76 TeV using the ALICE detector for six different centrality classes covering 0-80%. The proton-to-pion and the kaon-to-pion ratios both show a distinct peak at pT≈3 GeV/c in central Pb-Pb collisions that decreases towards more peripheral collisions. For pT>10 GeV/c, the nuclear modification factor is found to be the same for all three particle species in each centrality interval within systematic uncertainties of 10-20%. This suggests there is no direct interplay between the energy loss in the medium and the particle species composition in the hard core of the quenched jet. For pT<10 GeV/c, the data provide important constraints for models aimed at describing the transition from soft to hard physics.
Transverse momentum (pT) spectra of pions, kaons, and protons up to pT=20 GeV/c have been measured in Pb-Pb collisions at sNN−−−√=2.76 TeV using the ALICE detector for six different centrality classes covering 0-80%. The proton-to-pion and the kaon-to-pion ratios both show a distinct peak at pT≈3 GeV/c in central Pb-Pb collisions that decreases towards more peripheral collisions. For pT>10 GeV/c, the nuclear modification factor is found to be the same for all three particle species in each centrality interval within systematic uncertainties of 10-20%. This suggests there is no direct interplay between the energy loss in the medium and the particle species composition in the hard core of the quenched jet. For pT<10 GeV/c, the data provide important constraints for models aimed at describing the transition from soft to hard physics.